LG Life Sciences to raise overseas sales to 60%

Published: 2010-02-01 06:56:00

Updated: 2010-02-01 06:56:00

LG Life Sciences (LGLS) painted a rosy picture for the company’s pharmaceutical business, saying it will increase its overseas sales by 60% in 2015, a company executive said on January 27.

“Biopharmaceutical businesses to explore profitable biosimilar products will be the company’s next growth...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK